Psoriasis Terminated Phase 1 / 2 Trials for Folic Acid (DB00158)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01704599Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque PsoriasisTreatment